<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent literature suggests an increasing incidence of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> in young patients </plain></SENT>
<SENT sid="1" pm="."><plain>We performed a histologic, molecular, and immunophenotypic analysis of patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> early-<z:hpo ids='HP_0003674'>onset</z:hpo> (≤40 years of age) colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> seen at our institution from the years 2000-2010 and compared these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> to a cohort of consecutively resected colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> seen in patients &gt;40 years of age </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 1160 primary colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> were surgically resected for the years 2000 through 2010 </plain></SENT>
<SENT sid="3" pm="."><plain>Of these, 75 (6%) were diagnoses in patients ≤40 years of age of which 13 (17%) demonstrated abnormalities in DNA mismatch repair, 4 (5%) were in patients with known germline <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorders</z:e> (two patients with <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e>, one patient with <z:e sem="disease" ids="C0345893" disease_type="Neoplastic Process" abbrv="JPS|JIP|PJI">juvenile polyposis</z:e>, and one patient with <z:e sem="disease" ids="C0085390" disease_type="Neoplastic Process" abbrv="LFS">Li-Fraumeni syndrome</z:e>), and three patients (4%) had long-standing <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:hpo ids='HP_0003745'>sporadic</z:hpo> early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group comprised a total of 55 patients (55/1160, 5%) and were compared with a control group comprising 73 consecutively resected colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> with proficient DNA mismatch repair in patients &gt;40 years of age </plain></SENT>
<SENT sid="5" pm="."><plain>For the early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group, most cases (33/55, 60%) were diagnosed between the age of 35 and 40 years of age </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with the control group, the early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group was significantly different with respect to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location (P&lt;0.007) with 80% (44/55 cases) identified in either the sigmoid colon (24/55, 44%) or rectum (20/55, 36%) </plain></SENT>
<SENT sid="7" pm="."><plain>Morphologically, early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> more frequently displayed adverse histologic features compared with the control colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group such as signet ring cell differentiation (7/55, 13% vs 1/73, 1%, P=0.021), perineural invasion (16/55, 29% vs 8/73, 11%, P=0.009) and venous invasion (12/55, 22% vs 4/73, 6%, P=0.006) </plain></SENT>
<SENT sid="8" pm="."><plain>A precursor adenomatous lesion was less frequently identified in the early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group compared with the control group (19/55, 35% vs 39/73, 53%, P=0.034) </plain></SENT>
<SENT sid="9" pm="."><plain>Of the early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, only 2/45 cases (4%) demonstrated KRAS mutations compared with 11/73 (15%) of the control group colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> harboring KRAS mutations, although this difference did not reach statistical significance (P=0.13) </plain></SENT>
<SENT sid="10" pm="."><plain>BRAF V600E mutations were not identified in the early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group </plain></SENT>
<SENT sid="11" pm="."><plain>No difference was identified between the two groups with regard to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, number of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e>, lymphatic invasion, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding, mucinous histology, or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating lymphocytes </plain></SENT>
<SENT sid="12" pm="."><plain>Both groups had similar recurrence-free (P=0.28) and overall survival (P=0.73) </plain></SENT>
<SENT sid="13" pm="."><plain>However, patients in the early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group more frequently either presented with or developed <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> during their disease course compared with the control colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group (25/55, 45% vs 18/73, 25%, P=0.014) </plain></SENT>
<SENT sid="14" pm="."><plain>In addition, 8/55 patients (15%) in the early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group developed local recurrence of their <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> while no patients in the control colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> group developed local recurrence (P&lt;0.001), likely due to the increased incidence of rectal <z:mp ids='MP_0002038'>carcinoma</z:mp> in the patients with early-<z:hpo ids='HP_0003674'>onset</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="15" pm="."><plain>Our study demonstrates that colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> is not infrequently diagnosed in patients ≤40 years of age and is not frequently the result of underlying <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> or associated with other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-predisposing <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic conditions</z:e> or <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory conditions </plain></SENT>
<SENT sid="16" pm="."><plain>These <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> have a striking predilection for the distal colon, particularly the sigmoid colon and rectum and are much more likely to demonstrate adverse histologic factors, including signet ring cell differentiation, venous invasion, and perineural invasion </plain></SENT>
</text></document>